Avoro Capital Advisors
Signal active
Investment Firm
Overview
Avoro Capital Advisors is a global life sciences investment firm with a focus on supporting emerging biotechnology companies. Formerly known as venBio Select Advisor, ITwas established in 2010 and is headquartered in New York, United States.
Highlights
Founded
2010
Industry
Financial Services
Employees
11-50
Investment
16
Lead Investment
3
Exits
14
Stages
Early Stage Venture, Late Stage Venture
Investor Type
Private Equity Firm
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Avoro Capital Advisors, established in 2010 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Financial Services, Venture Capital, Finance, Health Care, Business Development, Hedge Funds, Biotechnology, Life Science, Biopharma, Oncology. The organization boasts a portfolio of 16 investments, with an average round size of $118.8M and 14 successful exits. Their recent investments include Vivo Capital, RTW Investments, Redmile Group, Aadi Bioscience, T. Rowe Price. The highest investment round they participated in was $226.7B. Among their most notable exits are Vivo Capital and RTW Investments. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Avoro Capital Advisors has made 16 investments. Their most recent investment was on Sep 22, 2022, when Aadi Bioscience raised $72.5M.
Avoro Capital Advisors has made 3 diversity investments. Their most recent diversity investment was on Aug 11, 2021, when Tango Therapeutics raised $186.0M.
investments
16
Diversity investments
3
Lead investments
3
Number of exits
14
Investments
16
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Aug 26, 2021 | Aadi Bioscience | Biotechnology | 155.0M |
| Aug 19, 2022 | - | - | 150.0M |
| Sep 22, 2022 | Aadi Bioscience | Biotechnology | 72.5M |
| May 21, 2023 | - | - | 160.0M |
Exits
14
Funding Timeline
Funding rounds
16
Investors
0
Funds
0
Funding Rounds
16
Avoro Capital Advisors has raised 16 rounds. Their latest funding was raised on May 21, 2023 from a Post-IPO Equity - Krystal Biotech round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Aug 26, 2021 | Post-IPO Equity - Aadi Bioscience | - | 155.0M | - |
| Aug 19, 2022 | Post-IPO Equity - Kymera Therapeutics | - | 150.0M | - |
| Sep 22, 2022 | Post-IPO Equity - Aadi Bioscience | - | 72.5M | - |
| May 21, 2023 | Post-IPO Equity - Krystal Biotech | - | 160.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.